Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIUHE.AS(EUR) CXE
ETF TickerIUHE(EUR) Euronext Amsterdam

Holdings detail for TECH

Stock NameBio-Techne Corp
TickerTECH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09073M1045
LEI54930073RLKQ51TILZ35

Show aggregate TECH holdings

News associated with TECH

Royal Bank Of Canada Upgrades Bio-Techne (NASDAQ:TECH) to “Moderate Buy”
Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by equities research analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other analysts have also recently issued reports on TECH. UBS Group lowered their target price on shares of Bio-Techne from […] - 2025-09-05 05:36:53
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,511,260 shares of the biotechnology company’s stock after buying an additional 45,570 shares during the quarter. […] - 2025-08-13 05:12:55
How The Pieces Add Up: TCAF Headed For $40
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-29 10:39:29
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Cwm LLC
Cwm LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,927 shares of the biotechnology company’s stock after selling 786 shares during the quarter. Cwm LLC’s holdings in Bio-Techne […] - 2025-07-24 04:47:00
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Signaturefd LLC
Signaturefd LLC decreased its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,690 shares of the biotechnology company’s stock after selling 293 shares during the quarter. Signaturefd LLC’s holdings in Bio-Techne were […] - 2025-07-21 05:43:00
Mutual of America Capital Management LLC Has $3.25 Million Stock Holdings in Bio-Techne Corp (NASDAQ:TECH)
Mutual of America Capital Management LLC raised its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 29.8% in the 1st quarter, HoldingsChannel reports. The fund owned 55,493 shares of the biotechnology company’s stock after acquiring an additional 12,740 shares during the period. Mutual of America Capital Management LLC’s holdings in Bio-Techne were worth $3,254,000 […] - 2025-07-18 05:16:49
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Xponance Inc.
Xponance Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,540 shares of the biotechnology company’s stock after purchasing an additional 619 shares during the period. Xponance […] - 2025-07-16 06:24:53
Cerity Partners LLC Grows Position in Bio-Techne Corp (NASDAQ:TECH)
Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 20.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 132,742 shares of the biotechnology company’s stock after purchasing an additional 22,259 shares during the quarter. Cerity Partners LLC’s holdings in Bio-Techne were worth $7,783,000 at the end […] - 2025-07-16 05:38:08
DekaBank Deutsche Girozentrale Sells 261 Shares of Bio-Techne Corp (NASDAQ:TECH)
DekaBank Deutsche Girozentrale lowered its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,926 shares of the biotechnology company’s stock after selling 261 shares during the quarter. DekaBank Deutsche […] - 2025-07-14 05:34:48
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. lessened its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 5.1% during the first quarter, HoldingsChannel reports. The fund owned 4,960 shares of the biotechnology company’s stock after selling 269 shares during the period. Vontobel Holding Ltd.’s holdings in Bio-Techne were worth $291,000 at the end of the most […] - 2025-07-09 05:02:49
GAMMA Investing LLC Lowers Stake in Bio-Techne Corp (NASDAQ:TECH)
GAMMA Investing LLC reduced its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 38.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,795 shares of the biotechnology company’s stock after selling 1,101 shares during the quarter. GAMMA Investing LLC’s holdings in […] - 2025-07-07 04:17:11
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC raised its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 11,210 shares of the biotechnology company’s stock after acquiring an additional 490 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Bio-Techne were worth $657,000 at the end […] - 2025-07-02 05:43:07
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Diversified Trust Co
Diversified Trust Co grew its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,824 shares of the biotechnology company’s stock after buying an additional 1,260 shares during the quarter. […] - 2025-06-30 05:10:55
Bessemer Group Inc. Sells 61,323 Shares of Bio-Techne Corp (NASDAQ:TECH)
Bessemer Group Inc. decreased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 75.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,748 shares of the biotechnology company’s stock after selling 61,323 shares during the quarter. Bessemer […] - 2025-06-30 04:38:49
Chevy Chase Trust Holdings LLC Sells 2,582 Shares of Bio-Techne Corp (NASDAQ:TECH)
Chevy Chase Trust Holdings LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,909 shares of the biotechnology company’s stock after selling 2,582 shares during the quarter. Chevy Chase Trust […] - 2025-06-27 05:12:48
Retirement Systems of Alabama Sells 430 Shares of Bio-Techne Corp (NASDAQ:TECH)
Retirement Systems of Alabama lessened its stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The firm owned 33,972 shares of the biotechnology company’s stock after selling 430 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $1,992,000 at the end of the most […] - 2025-06-26 06:06:47
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 67,166 shares of the biotechnology company’s stock after acquiring an additional 2,929 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Bio-Techne were worth $3,938,000 at […] - 2025-06-26 05:16:55
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 21.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,803 shares of the biotechnology company’s stock after buying an additional 490 shares during the quarter. Exchange […] - 2025-06-24 04:36:51
CX Institutional Invests $27,000 in Bio-Techne Corp (NASDAQ:TECH)
CX Institutional acquired a new position in Bio-Techne Corp (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 459 shares of the biotechnology company’s stock, valued at approximately $27,000. Several other large investors also […] - 2025-06-19 04:52:57
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of “Hold” from Brokerages
Bio-Techne Corp (NASDAQ:TECH – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts […] - 2025-06-18 06:12:46
Mn Services Vermogensbeheer B.V. Sells 6,200 Shares of Bio-Techne Corp (NASDAQ:TECH)
Mn Services Vermogensbeheer B.V. trimmed its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,200 shares of the biotechnology company’s stock after selling 6,200 shares during the quarter. Mn Services […] - 2025-06-18 05:32:53
Bio-Techne (NASDAQ:TECH) Cut to Hold at Wall Street Zen
Wall Street Zen lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday. Several other analysts have also commented on the stock. Citigroup lowered their price target on shares of Bio-Techne from $80.00 to $70.00 and set a “neutral” rating […] - 2025-06-09 03:44:45
Rhumbline Advisers Increases Position in Bio-Techne Co. (NASDAQ:TECH)
Rhumbline Advisers lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 300,474 shares of the biotechnology company’s stock after acquiring an additional 39,345 shares during the quarter. Rhumbline Advisers’ holdings in Bio-Techne were worth $17,617,000 as of its most recent filing […] - 2025-06-08 05:35:05
Squarepoint Ops LLC Buys 4,816 Shares of Bio-Techne Co. (NASDAQ:TECH)
Squarepoint Ops LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 113.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,060 shares of the biotechnology company’s stock after buying an additional 4,816 shares during […] - 2025-06-03 05:06:58
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.08 Million in Bio-Techne Co. (NASDAQ:TECH)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 56,666 shares of the biotechnology company’s stock, valued at approximately $4,082,000. Other hedge funds and other institutional investors […] - 2025-06-02 05:36:54
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Two Sigma Advisers LP
Two Sigma Advisers LP trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,900 shares of the biotechnology company’s stock after selling 900 shares during the quarter. Two Sigma Advisers […] - 2025-06-01 05:44:50
How The Parts Add Up: XLV Headed For $158
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:22:41
Cetera Investment Advisers Decreases Position in Bio-Techne Co. (NASDAQ:TECH)
Cetera Investment Advisers lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,857 shares of the biotechnology company’s stock after selling 887 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Techne were worth $1,430,000 at the end of the most recent […] - 2025-05-22 04:52:55
Bank of America Corp DE Sells 303,523 Shares of Bio-Techne Co. (NASDAQ:TECH)
Bank of America Corp DE cut its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 37.0% during the 4th quarter, Holdings Channel reports. The fund owned 516,549 shares of the biotechnology company’s stock after selling 303,523 shares during the period. Bank of America Corp DE’s holdings in Bio-Techne were worth $37,207,000 as of its […] - 2025-05-16 05:31:04
Mercer Global Advisors Inc. ADV Reduces Stake in Bio-Techne Co. (NASDAQ:TECH)
Mercer Global Advisors Inc. ADV decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,028 shares of the biotechnology company’s stock after selling 751 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Bio-Techne were worth $290,000 at the […] - 2025-05-16 04:49:06

iShares S&P 500 Health Care Sector UCITS ETF TECH holdings

DateNumber of TECH Shares HeldBase Market Value of TECH SharesLocal Market Value of TECH SharesChange in TECH Shares HeldChange in TECH Base ValueCurrent Price per TECH Share HeldPrevious Price per TECH Share Held
2025-09-18 (Thursday)73,873TECH holding increased by 87USD 3,914,530TECH holding increased by 113075USD 3,914,53087USD 113,075 USD 52.99 USD 51.52
2025-09-17 (Wednesday)73,786USD 3,801,455TECH holding decreased by -19184USD 3,801,4550USD -19,184 USD 51.52 USD 51.78
2025-09-16 (Tuesday)73,786USD 3,820,639TECH holding increased by 11806USD 3,820,6390USD 11,806 USD 51.78 USD 51.62
2025-09-15 (Monday)73,786USD 3,808,833USD 3,808,833
2025-09-12 (Friday)73,786USD 3,782,270USD 3,782,270
2025-09-11 (Thursday)73,557TECH holding increased by 87USD 3,913,968TECH holding increased by 169937USD 3,913,96887USD 169,937 USD 53.21 USD 50.96
2025-09-10 (Wednesday)73,470TECH holding increased by 87USD 3,744,031TECH holding decreased by -233328USD 3,744,03187USD -233,328 USD 50.96 USD 54.2
2025-09-09 (Tuesday)73,383USD 3,977,359TECH holding increased by 6605USD 3,977,3590USD 6,605 USD 54.2 USD 54.11
2025-09-08 (Monday)73,383USD 3,970,754USD 3,970,754
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TECH by Blackrock for IE00BMBKBZ46

Show aggregate share trades of TECH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY87 52.990* 59.39
2025-09-11BUY87 53.210* 59.51
2025-09-10BUY87 50.960* 59.56
2025-08-20BUY172 54.330* 59.65
2025-08-19BUY86 54.870* 59.68
2025-08-18BUY430 53.290* 59.72
2025-08-15BUY1,295 53.600* 59.75
2025-08-14BUY522 53.740* 59.79
2025-08-13BUY348 54.710* 59.82
2025-07-30BUY86 57.710* 59.87
2025-07-17SELL-86 53.290* 60.13 Profit of 5,172 on sale
2025-07-15SELL-344 51.420* 60.24 Profit of 20,724 on sale
2025-07-14SELL-860 52.620* 60.29 Profit of 51,852 on sale
2025-07-09SELL-86 52.590* 60.42 Profit of 5,196 on sale
2025-07-07SELL-172 51.535* 60.54 Profit of 10,412 on sale
2025-07-02BUY86 53.180* 60.69
2025-06-24SELL-1,479 50.000* 61.01 Profit of 90,233 on sale
2025-06-23BUY87 49.300* 61.09
2025-06-20SELL-174 49.890* 61.17 Profit of 10,644 on sale
2025-06-18SELL-87 50.130* 61.34 Profit of 5,336 on sale
2025-06-17BUY1,044 49.500* 61.42
2025-06-13SELL-174 50.520* 61.58 Profit of 10,714 on sale
2025-06-11SELL-87 51.540* 61.73 Profit of 5,370 on sale
2025-06-10SELL-174 51.400* 61.81 Profit of 10,755 on sale
2025-06-09SELL-261 49.880* 61.90 Profit of 16,156 on sale
2025-05-21SELL-87 46.660* 63.43 Profit of 5,519 on sale
2025-05-20SELL-174 49.530* 63.55 Profit of 11,058 on sale
2025-05-15SELL-261 48.240* 63.94 Profit of 16,689 on sale
2025-05-14SELL-261 47.860* 64.09 Profit of 16,727 on sale
2025-05-13BUY87 51.610* 64.20
2025-05-09SELL-87 49.940* 64.42 Profit of 5,605 on sale
2025-05-08BUY174 49.780* 64.56
2025-05-01BUY174 49.630* 65.30
2025-04-24SELL-87 50.780* 66.06 Profit of 5,747 on sale
2025-04-23BUY261 50.160* 66.23
2025-04-15SELL-87 51.070* 67.36 Profit of 5,861 on sale
2025-04-10SELL-170 49.260* 67.93 Profit of 11,547 on sale
2025-04-08SELL-85 48.810* 68.31 Profit of 5,806 on sale
2025-04-07SELL-85 52.310* 68.50 Profit of 5,822 on sale
2025-04-04SELL-170 51.720* 68.70 Profit of 11,679 on sale
2025-04-02BUY85 58.380* 68.82
2025-04-01BUY765 57.350* 68.96
2025-03-31SELL-510 58.630* 69.09 Profit of 35,235 on sale
2025-03-28BUY85 58.730* 69.22
2025-03-26SELL-55 59.380* 69.46 Profit of 3,820 on sale
2025-03-21BUY595 60.610* 69.82
2025-03-20BUY344 60.340* 69.95
2025-03-17SELL-86 62.580* 70.28 Profit of 6,044 on sale
2025-03-12SELL-489 60.235* 70.70 Profit of 34,572 on sale
2025-03-07BUY87 64.370* 71.11
2025-02-28SELL-261 61.750* 71.75 Profit of 18,726 on sale
2025-02-25BUY870 64.220* 72.19
2025-02-20BUY609 65.490* 72.56
2025-02-19BUY261 65.800* 72.69
2025-02-18BUY174 65.290* 72.83
2025-02-13BUY435 66.770* 73.23
2025-02-04BUY348 72.550* 73.49
2025-01-31BUY87 73.550* 73.52
2025-01-29BUY87 71.830* 73.58
2025-01-27BUY174 76.450* 73.48
2025-01-24BUY87 77.050* 73.38
2025-01-02SELL-3,128 71.480* 73.33 Profit of 229,381 on sale
2024-12-10SELL-86 77.120* 73.22 Profit of 6,297 on sale
2024-12-09SELL-2,236 77.400* 73.09 Profit of 163,420 on sale
2024-12-03SELL-1,032 75.050* 72.84 Profit of 75,167 on sale
2024-12-02SELL-430 76.020* 72.72 Profit of 31,269 on sale
2024-11-29SELL-87 75.360* 72.62 Profit of 6,318 on sale
2024-11-22SELL-860 71.280* 72.23 Profit of 62,114 on sale
2024-11-21SELL-430 71.050* 72.28 Profit of 31,082 on sale
2024-11-20BUY688 68.720* 72.47
2024-11-18SELL-1,032 66.860* 73.16 Profit of 75,502 on sale
2024-11-11BUY774 74.690* 72.98
2024-11-08SELL-2,752 75.960* 72.76 Profit of 200,241 on sale
2024-11-07SELL-170 76.420* 72.48 Profit of 12,322 on sale
2024-11-01SELL-170 75.310* 70.84 Profit of 12,043 on sale
2024-10-31SELL-344 73.750* 70.48 Profit of 24,245 on sale
2024-10-30BUY86 76.020* 69.69
2024-10-29BUY516 70.740* 69.51
2024-10-28SELL-258 70.380* 69.34 Profit of 17,890 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TECH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19651,35111,081870,85674.8%
2025-09-18364,7260635,89757.4%
2025-09-17271,704109711,34538.2%
2025-09-16359,43201,639,77821.9%
2025-09-15279,70130759,61936.8%
2025-09-12389,4061,558859,94245.3%
2025-09-11291,39729720,35140.5%
2025-09-10623,442211,428,22043.7%
2025-09-09496,5733171,091,06945.5%
2025-09-08324,673215797,10140.7%
2025-09-05300,894351736,45040.9%
2025-09-04298,14550849,32735.1%
2025-09-03396,4460721,67254.9%
2025-09-02157,8040635,17724.8%
2025-08-29267,6043,210620,56843.1%
2025-08-28552,63101,621,66434.1%
2025-08-27319,849448770,75941.5%
2025-08-26501,622768647,13777.5%
2025-08-25403,253775980,20941.1%
2025-08-22345,299759513,18267.3%
2025-08-21321,8404618,18452.1%
2025-08-20340,4275602,03456.5%
2025-08-19355,2340523,53767.9%
2025-08-18257,2510489,73252.5%
2025-08-15172,7352321,97653.6%
2025-08-14267,327265566,98647.1%
2025-08-13301,96036655,81446.0%
2025-08-12336,42393800,31842.0%
2025-08-11335,295637799,43341.9%
2025-08-08425,18121,371853,69549.8%
2025-08-07562,06246,8941,314,23842.8%
2025-08-061,493,78312,2823,400,01843.9%
2025-08-05325,3055,603950,69834.2%
2025-08-04295,3211,870616,19947.9%
2025-08-01382,01610,466684,12755.8%
2025-07-31403,7771,690959,80042.1%
2025-07-30313,8576,379528,86459.3%
2025-07-29438,3262,402761,35057.6%
2025-07-28682,9256,9001,041,30065.6%
2025-07-25615,59726,3711,044,88258.9%
2025-07-241,073,71263,0372,073,18551.8%
2025-07-23529,3193,7241,012,04152.3%
2025-07-22346,5822,688608,36257.0%
2025-07-21871,04541,362,95163.9%
2025-07-18384,0621,700787,47848.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.